1.78
price down icon1.11%   -0.02
after-market Dopo l'orario di chiusura: 1.72 -0.06 -3.37%
loading
Precedente Chiudi:
$1.80
Aprire:
$1.82
Volume 24 ore:
10,525
Relative Volume:
0.79
Capitalizzazione di mercato:
$12.59M
Reddito:
-
Utile/perdita netta:
$-33.65M
Rapporto P/E:
-0.40
EPS:
-4.45
Flusso di cassa netto:
$-20.83M
1 W Prestazione:
+0.56%
1M Prestazione:
+19.46%
6M Prestazione:
-21.24%
1 anno Prestazione:
-41.64%
Intervallo 1D:
Value
$1.75
$1.82
Intervallo di 1 settimana:
Value
$1.75
$1.8812
Portata 52W:
Value
$1.15
$3.499

Minerva Neurosciences Inc Stock (NERV) Company Profile

Name
Nome
Minerva Neurosciences Inc
Name
Telefono
617-600-7373
Name
Indirizzo
1601 TRAPELO ROAD, WALTHAM, MA
Name
Dipendente
8
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
NERV's Discussions on Twitter

Confronta NERV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NERV
Minerva Neurosciences Inc
1.78 12.59M 0 -33.65M -20.83M -4.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-06-08 Reiterato H.C. Wainwright Buy
2020-05-14 Iniziato BTIG Research Buy
2019-10-02 Reiterato Chardan Capital Markets Buy
2019-09-25 Iniziato Chardan Capital Markets Buy
2019-09-18 Iniziato William Blair Outperform
2019-05-31 Iniziato H.C. Wainwright Buy
2017-09-01 Iniziato Citigroup Buy
2017-03-06 Ripresa Jefferies Buy
2016-05-12 Ripresa Jefferies Buy
Mostra tutto

Minerva Neurosciences Inc Borsa (NERV) Ultime notizie

pulisher
Jun 12, 2025

Citadel Advisors LLC Makes New Investment in Kuke Music Holding Limited (NYSE:KUKE) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Purchases New Holdings in Jiuzi Holdings, Inc. (NASDAQ:JZXN) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares Bought by Citadel Advisors LLC - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges - TipRanks

Jun 10, 2025
pulisher
Jun 04, 2025

Major Depressive Disorder Pipeline Appears Robust With 75+ Key Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares Bought by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
May 23, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at Wall Street Zen - Defense World

May 23, 2025
pulisher
May 14, 2025

Minerva Neurosciences: Q1 Earnings Snapshot - CT Insider

May 14, 2025
pulisher
May 13, 2025

Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

NERV's Cash Reserves Decrease by $4.1 Million in Q1 2025 | NERV Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Minerva Neurosciences Reports First Quarter 2025 Financial Resul - GuruFocus

May 13, 2025
pulisher
May 13, 2025

MINERVA NEUROSCIENCES Earnings Results: $NERV Reports Quarterly Earnings - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Minerva Neurosciences, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated by Analysts at StockNews.com - Defense World

May 13, 2025
pulisher
May 06, 2025

Minerva Neurosciences (NERV) Expected to Announce Quarterly Earnings on Wednesday - Defense World

May 06, 2025
pulisher
May 06, 2025

Renaissance Technologies LLC Has $285,000 Stock Holdings in Minerva Neurosciences, Inc. (NASDAQ:NERV) - Defense World

May 06, 2025
pulisher
May 05, 2025

Minerva Neurosciences (NASDAQ:NERV) Now Covered by Analysts at StockNews.com - Defense World

May 05, 2025
pulisher
May 01, 2025

Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight - GlobeNewswire Inc.

May 01, 2025
pulisher
May 01, 2025

Schizophrenia Market to Witness Significant Growth by 2034 - GlobeNewswire

May 01, 2025
pulisher
Apr 27, 2025

StockNews.com Initiates Coverage on Minerva Neurosciences (NASDAQ:NERV) - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 19, 2025

Minerva Neurosciences (NASDAQ:NERV) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World

Apr 19, 2025
pulisher
Apr 19, 2025

Minerva Neurosciences (NASDAQ:NERV) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 19, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 14, 2025
pulisher
Apr 13, 2025

StockNews.com Begins Coverage on Minerva Neurosciences (NASDAQ:NERV) - The AM Reporter

Apr 13, 2025
pulisher
Apr 10, 2025

CLASS ACTION UPDATE for TILE, NERV and QSR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 09, 2025

CLASS ACTION UPDATE for BABA, NAK and NERV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 08, 2025

Parkinson's Disease Pipeline Analysis and Clinical Trials - openPR.com

Apr 08, 2025
pulisher
Apr 04, 2025

Minerva Neurosciences stock hits 52-week low at $1.29 - Investing.com Australia

Apr 04, 2025
pulisher
Apr 04, 2025

Minerva Neurosciences stock hits 52-week low at $1.29 By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Mar 24, 2025

Major depressive disorder Drugs Market 2034: Clinical Trials, - openPR.com

Mar 24, 2025
pulisher
Mar 20, 2025

Minerva Neurosciences regains Nasdaq compliance By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Minerva Neurosciences regains Nasdaq compliance - Investing.com India

Mar 20, 2025
pulisher
Mar 19, 2025

FINAL DEADLINE ALERT: ROSEN, LEADING AND RESPECTED INVESTOR COUNSEL, Encourages Minerva Neurosciences, Inc. Investors with Large Losses to Secure Counsel Before Important February 8 Deadline – NERV - Business Wire

Mar 19, 2025
pulisher
Mar 13, 2025

Parkinson's Disease Clinical Pipeline | 130+ Companies Advancing the Future of Treatment - openPR

Mar 13, 2025
pulisher
Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld MedTech

Mar 07, 2025
pulisher
Mar 05, 2025

Minerva Neurosciences Reports Improved 2024 Financials - TipRanks

Mar 05, 2025
pulisher
Mar 02, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at StockNews.com - Defense World

Mar 02, 2025

Minerva Neurosciences Inc Azioni (NERV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):